Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|March 1, 2008
- Volume 0 0
...AND ID NEEDED FOR Rx PICKUPS IN NM
Advertisement
In a move recommended by the state?s pharmacyboard, New Mexico is now requiring anyone who picks updrugs for another person to present government-issuedphoto identification, such as a driver?s license or state IDcard. It has been reported that attempts by individuals topick up prescriptions for others have dropped by 70%since the policy went into effect in the state January 1.
Articles in this issue
over 18 years ago
can you READ these Rxs?over 18 years ago
Case Studiesover 18 years ago
WOMEN'S HEALTH WATCHover 18 years ago
ASTHMA WATCHover 18 years ago
HYPERTENSION WATCHover 18 years ago
ARTHRITIS WATCHover 18 years ago
compounding HOTLINEover 18 years ago
DIABETES WATCHover 18 years ago
A Robotic Touch?Automating Your Pharmacyover 18 years ago
pharmacy TECHNOLOGY productsAdvertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5